Given the lack of available data and lack of published evidence on the efficacy and/or the effectiveness of the intervention, the researchers (and internal reviewers) of this ‘Costs and economic evaluation’ domain agreed that it would not be prudent to undertake research into costs or undertake an economic evaluation.
Renner A et al. Result Card ECO3 In: Renner A et al. Costs and economic evaluation In: Jefferson T, Cerbo M, Vicari N [eds.]. Use of Intravenous immunoglobulins for Alzeheimer’s disease including Mild Cognitive Impairment [Core HTA], Agenas - Agenzia nazionale per i servizi sanitari regionali ; 2015. [cited 24 September 2021]. Available from: http://corehta.info/ViewCover.aspx?id=267